Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.
J Am Acad Dermatol
; 80(5): 1344-1352, 2019 May.
Article
in En
| MEDLINE
| ID: mdl-30716404
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Psoriasis
/
Dermatologic Agents
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2019
Type:
Article